Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
暂无分享,去创建一个
M. Beasley | Ke Hao | D. Burstein | J. Hechtman | Yayoi Kinoshita | H. Ko
[1] Dakang Xu,et al. The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology , 2012, Front. Oncol..
[2] Y. Yatabe,et al. Histone H1 expression in human prostate cancer tissues and cell lines , 2012, Pathology international.
[3] M. J. Barrero,et al. Histone H1 Variants Are Differentially Expressed and Incorporated into Chromatin during Differentiation and Reprogramming to Pluripotency* , 2011, The Journal of Biological Chemistry.
[4] Jiaoti Huang,et al. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not. , 2011, Human pathology.
[5] I. Wistuba,et al. Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. , 2011, Human pathology.
[6] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[7] Natasha Rekhtman,et al. Neuroendocrine tumors of the lung: an update. , 2010, Archives of pathology & laboratory medicine.
[8] C. Compton,et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla. , 2010, Archives of pathology & laboratory medicine.
[9] S. Jhanwar,et al. The promyelocytic leukemia zinc finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival , 2009, Oncogene.
[10] D. Doenecke,et al. Histone H1 and its isoforms: contribution to chromatin structure and function. , 2009, Gene.
[11] G. Sica,et al. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. , 2008, American journal of clinical pathology.
[12] P. Bourne,et al. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. , 2007, Human pathology.
[13] W. Travis,et al. Pulmonary neuroendocrine tumors: What (little) do we know? , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.
[14] S. Yoshimura,et al. Linker histone H1 per se can induce three-dimensional folding of chromatin fiber. , 2005, Biochemistry.
[15] S. Pambuccian,et al. Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. , 2005, American journal of clinical pathology.
[16] A. Carè,et al. Role of PLZF in melanoma progression , 2004, Oncogene.
[17] M. Sheppard,et al. Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.
[18] J. Licht,et al. The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.
[19] W. Travis,et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. , 1998, The American journal of surgical pathology.
[20] V. Gouyer,et al. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. , 1998, American journal of respiratory cell and molecular biology.
[21] E. Brambilla,et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. , 1996, The American journal of pathology.
[22] V. Rusch,et al. Molecular markers help characterize neuroendocrine lung tumors. , 1996, The Annals of thoracic surgery.
[23] M. Barbareschi,et al. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms , 1992, The Journal of pathology.
[24] W. Travis,et al. Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases , 1991, The American journal of surgical pathology.
[25] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .